According to a new report, published by KBV research, The Global Automated Cell Counting Market size is expected to reach $8.6 billion by 2030, rising at a market growth of 12.2% CAGR during the forecast period.
The Instruments segment would exhibit a CAGR of 11.8% during (2023 - 2030). Ongoing advancements in life sciences, biotechnology, and pharmaceutical research have increased the need for automated cell-counting instruments. Researchers require efficient and accurate tools to handle large volumes of cell samples for experiments, drug development, and studying diseases. The demand for instruments continues to grow due to technological advancements, expanding applications in research and diagnostics, increased awareness of the importance of cell analysis, and the pursuit of more efficient and accurate laboratory workflows.
The Cell Line development segment is generating highest revenue in the Global Automated Cell Counting Market by Application in 2022; thereby, achieving a market value of $3.1 billion by 2030. The use of automated cell counters in cell line development offers benefits such as improved accuracy, time savings, labor efficiency, and standardization, making them an attractive option for researchers in this field. Automated cell counters can analyze samples much faster than manual counting methods, saving time and increasing throughput in cell line development workflows.
The Research Academic Institutes segment is experiencing a CAGR of 13.2% during (2023 - 2030). Several research and academic institutions worldwide actively contribute to developing, advancing, and utilizing automated cell counting technology. These institutions conduct cutting-edge research, provide education, and serve as hubs for innovation in this field. These institutions, among others worldwide, contribute significantly to advancing automated cell counting technology by integrating it into various research projects spanning diverse disciplines.
The North America region dominated the Global Automated Cell Counting Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $3.1 billion by 2030. The Europe region is anticipated to grow at a CAGR of 11.8% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 13% during (2023 - 2030).
Full Report:https://www.kbvresearch.com/automated-cell-counting-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.), Thermo Fisher Scientific, Inc., Bio-Rad laboratories, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Olympus Corporation, Merck KGaA, Abbott Laboratories, Sysmex Corporation, and Agilent Technologies, Inc.
By Product
By Application
By End-use
By Geography
Companies Profiled
Unique Offerings 
